Early versus late discharge after transcatheter aortic valve replacement and readmissions for permanent pacemaker implantation

Objective To examine the rate of readmission for permanent pacemaker (PPM) implantation with early versus late discharge after transcatheter aortic valve replacement (TAVR). Background There is a current trend toward early discharge after TAVR. However, paucity of data exists on the impact of such p...

Full description

Saved in:
Bibliographic Details
Published in:Catheterization and cardiovascular interventions 2022-08, Vol.100 (2), p.245-253
Main Authors: Elzanaty, Ahmed M., Maraey, Ahmed, Elbadawi, Ayman, Khalil, Mahmoud, Hashim, Ahmed, Vyas, Rohit, Moustafa, Abdelmoneim, Ramanthan, Periakaruppan Kasi, Mentias, Amgad, Abbott, J. Dawn, Aronow, Herbert D., Kapadia, Samir, Saad, Marwan
Format: Article
Language:English
Subjects:
Aortic valve
Clinical trials
conduction abnormalities
discharge timing
Hospitalization
Pacemakers
Patients
permanent pacemaker implantation
TAVR
transcatheter aortic valve replacement
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective To examine the rate of readmission for permanent pacemaker (PPM) implantation with early versus late discharge after transcatheter aortic valve replacement (TAVR). Background There is a current trend toward early discharge after TAVR. However, paucity of data exists on the impact of such practice on readmissions for PPM implantation. Methods The Nationwide Readmission Database 2016–2018 was queried for all hospitalizations where patients underwent TAVR. Hospitalizations were stratified into early (Days 0 and 1) versus late (≥Day 2) discharge groups. Observations in which PPM was required in the index admission were excluded. Multivariable regression analyses involving patient‐ and hospital‐related variables were utilized. The primary outcome was 90‐day readmission for PPM implantation. Results The final analysis included 68,482 TAVR hospitalizations, 20,261 (29.6%) with early versus 48,221 (70.4%) with late discharge. Early discharge after TAVR increased over the study period (16.2% in 2016 vs. 37.9% in 2018, Ptrend 
ISSN:1522-1946
1522-726X
DOI:10.1002/ccd.30299